Balance Sheet (unaudited) (USD $)	Jan. 31, 2013	Jul. 31, 2012
Current assets
Cash and cash equivalents	$ 151,700	$ 20,423
Total current assets	151,700	20,423
Other assets
Patents and patent applications (net of accumulated amortizaton of $3,583 at January 31, 2013 and $2,897 at July 31, 2012)	23,867	24,553
Total assets	175,567	44,976
Liabilities
Accounts payable and accrued liabilities	60,485	55,497
Accrued salaries and wages	85,471	56,300
Due to related party	470,152	136,412
Convertible notes payable, net of debt discounts	324,023	223,693
Derivative liability	262,811	191,792
Total liabilities	1,202,942	663,694
Stockholders' equity (deficit)
Common stock; par value $0.001; 200,000,000 shares authorized; 132,761,859 shares issued and outstanding at January 31, 2013 and 126,083,416 shares issued and outstanding at July 31, 2012	132,762	126,083
Additional paid-in capital	24,431,854	23,184,094
Accumulated deficit during the development stage	(25,591,991)	(23,928,895)
Total stockholders' equity (deficit)	(1,027,375)	(618,718)
Total liabilities and stockholders' equity(deficit)	$ 175,567	$ 44,976